Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Konstantinos Arnaoutakis

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Arnaoutakis, Konstantinos

PropertyValue
overview Dr. Konstantinos Arnaoutakis is a hematologist and oncologist at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences. He is also an Associate Professor in the Department of Internal Medicine, Division of Hematology and Oncology. Dr. Arnaoutakis received his medical degree from the University of Patras Medical School in Greece. He served an internal medicine residency at Albany Medical College-Albany Medical Center Hospital. He also served a fellowship in hematology and oncology at Tufts University, St. Elizabeth's Medical Center in Boston, MA. He later went on to serve as Chief Hematology and Medical Oncology Fellow at Tufts University. He is board certified in internal medicine, hematology and oncology. He is a member of the American Medical Association, American College of Physician, American Society of Clinical Oncology and American Society of Hematology. His primary research interests are lung cancer, head and neck cancer and genitourinary cancers.

One or more keywords matched the following items that are connected to Arnaoutakis, Konstantinos

Item TypeName
Academic Article Lung cancer in octogenarians.
Concept Lung Neoplasms
Concept Carcinoma, Non-Small-Cell Lung
Academic Article Gains of 2p23/ALK locus are common in non-small cell lung carcinoma: Clinical and molecular correlations
Academic Article Recurrent lung melanoma 20 years after previous cutaneous melanoma
Academic Article Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer
Academic Article Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer.
Academic Article Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Academic Article Hyalinizing Clear Cell Carcinoma of the Lung: Case Report and Review of the Literature.
Academic Article Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Academic Article PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin.
Grant Scientific and methodological advancement in liquid biopsies to further the development of lung cancer-based precision medicine
Grant Scientific and methodological advancement in liquid biopsies to further the development of lung cancer-based precision medicine
Academic Article Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed EGFR Mutant Non-Small-Cell Lung Cancer.
Grant S1900C: A Phase II Study of Talazoparib Plus Avelumab in Patients with Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer Bearing Pathogenic STK11 Genomic Alterations (LUNG-MAP Sub-Study) (260760)
Grant S1929, Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC) (273385)
Grant A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Tarlatamabin Subjects with Relapsed/Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment (DeLLphi-301)
Grant A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Tarlatamabin Subjects with Relapsed/Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment (DeLLphi-301)

Search Criteria
  • Lung